EVENT RESOURCES
- Wednesday, September 4, 2024
- Thursday, September 5, 2024
- Friday, September 6, 2024
- Saturday, September 7, 2024
Name | Time | Virtual Session Link |
---|---|---|
Session I: Acute Lymphoblastic Leukemia | 9:00 AM - 11:36 AM | Go To Session |
Plenary Session I | 12:56 PM - 1:16 PM | Go To Session |
Session II: Myelodysplastic Syndromes | 1:16 PM - 2:56 PM | Go To Session |
Session III: Acute Myeloid Leukemia | 3:26 PM - 6:00 PM | Go To Session |
Name | Time | Virtual Session Link |
---|---|---|
Session IV: Chronic Myeloid Leukemia | 8:00 AM - 9:40 AM | Go To Session |
Session V: MyeloproliferatIVe Neoplasms | 10:10 AM - 11:50 AM | Go To Session |
Plenary Session II | 1:20 PM - 1:40 PM | Go To Session |
Session VI: Multiple Myeloma | 1:40 PM - 3:56 PM | Go To Session |
Session VII: Chronic Lymphocytic Leukemia | 4:26 PM - 6:24 PM | Go To Session |
Name | Time | Virtual Session Link |
---|---|---|
Session VIII: T-Cell Lymphoma | 8:00 AM - 9:40 AM | Go To Session |
Session IX: Indolent B-Cell Lymphoma | 10:10 AM - 11:42 AM | Go To Session |
Plenary Session III | 1:07 PM - 1:27 PM | Go To Session |
Session X: Aggressive B-Cell Lymphoma | 1:27 PM - 3:35 PM | Go To Session |
Session XI: Mantle Cell Lymphoma | 4:05 PM - 5:17 PM | Go To Session |
Session XII: Hodgkin Lymphoma | 5:17 PM - 5:53 PM | Go To Session |
Name | Time | Virtual Session Link |
---|---|---|
Session XIII: Cellular therapy | 8:00 AM - 9:01 AM | Go To Session |
Session XIV: Next Questions | 9:36 AM - 11:56 PM | Go To Session |
Time Zone: (UTC-06:00) Central Time (US & Canada) [Change Time Zone]
Time Zone: (UTC-06:00) Central Time (US & Canada) [Change Time Zone]
Dr. Krish Patel MD
Providence Swedish Cancer Institute
Director, Hematologic Malignancies & Cellular Therapy
Providence Swedish Cancer Institute
Director, Hematologic Malignancies & Cellular Therapy
Dr. Stephane De Botton MD, PhD
Institut de Cancerologie Gustave Roussy
Physician, Clinical Investigator and Head of Drug Development in Acute Leukemias in the Department of Hematology
Institut de Cancerologie Gustave Roussy
Physician, Clinical Investigator and Head of Drug Development in Acute Leukemias in the Department of Hematology
Dr. Meletios Dimopoulos MD
National and Kapodistrian University of Athens School of Medicine
Professor and Chairman, Department of Clinical Therapeutics
National and Kapodistrian University of Athens School of Medicine
Professor and Chairman, Department of Clinical Therapeutics